These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2677809)

  • 1. Protein components of amyloid-like kidney stones of chronic hemodialysis patients.
    Ozasa H; Suzuki T; Takahashi K; Ota K
    Nephron; 1989; 53(3):257-60. PubMed ID: 2677809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix stones and acquired renal cysts in a non-dialysed patient with chronic renal failure.
    Branten AJ; Assmann KJ; Koene RA
    Nephrol Dial Transplant; 1995; 10(1):123-5. PubMed ID: 7724008
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis.
    Linke RP; Hampl H; Lobeck H; Ritz E; Bommer J; Waldherr R; Eulitz M
    Kidney Int; 1989 Oct; 36(4):675-81. PubMed ID: 2509779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of amyloid-like substance from beta-2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study.
    Ono K; Uchino F
    Nephron; 1994; 66(4):404-7. PubMed ID: 8015642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary matrix calculi consisting of microfibrillar protein in patients on maintenance hemodialysis.
    Bommer J; Ritz E; Tschöpe W; Waldherr R; Gebhardt M
    Kidney Int; 1979 Dec; 16(6):722-8. PubMed ID: 548610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of kidney stone formation in chronic hemodialysis patients.
    Ozasa H; Ota K
    Nephron; 1991; 58(2):242-3. PubMed ID: 1865986
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney lesions in uraemic patients and beta 2-microglobulin derived amyloid.
    Bommer J; Waldherr R; Ritz E
    Lancet; 1985 Dec 21-28; 2(8469-70):1437-8. PubMed ID: 2867441
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid urinary-tract calculi in patients on chronic dialysis.
    Watanabe K; Nakamura R; Kano S; Ohtake T; Hosoda Y; Saruta T
    Nephron; 1989; 52(4):334-7. PubMed ID: 2505148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition and removal of cutaneous beta 2-microglobulin.
    Spiegel DM; Costante N; Janiga AM; Haas M; Soltani K
    Am J Nephrol; 1992; 12(5):330-5. PubMed ID: 1489002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary matrix calculi consisting of low molecular weight protein in chronic uremic patients with hemodialysis (author's transl)].
    Nakayama M; Saito H; Satoh T
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1616-23. PubMed ID: 7345199
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis-related amyloidosis of the tongue.
    Yusa H; Yoshida H; Kikuchi H; Onizawa K
    J Oral Maxillofac Surg; 2001 Aug; 59(8):947-50. PubMed ID: 11474463
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of pyonephrosis caused by a protein calculus in a patient on hemodialysis].
    Shibasaki N; Kanno T; Tsuji Y; Taki Y; Takeuchi H
    Hinyokika Kiyo; 2004 Sep; 50(9):625-7. PubMed ID: 15518128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Calcium oxalate urinary-tract stones in patients on maintenance dialysis.
    Oreopoulos DG; Silverberg S
    N Engl J Med; 1974 Jun; 290(25):1438-9. PubMed ID: 4829568
    [No Abstract]   [Full Text] [Related]  

  • 14. C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis.
    Hasegawa M; Kawashima S; Shikano M; Kojima K; Yanai T; Hassegawa H; Tomita M; Murakami K; Kawamura N; Katsumata H
    Nephron; 1995; 69(4):380-3. PubMed ID: 7777100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments.
    Linke RP; Bommer J; Ritz E; Waldherr R; Eulitz M
    Biochem Biophys Res Commun; 1986 Apr; 136(2):665-71. PubMed ID: 3085673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
    Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.
    Shirahama T; Skinner M; Cohen AS; Gejyo F; Arakawa M; Suzuki M; Hirasawa Y
    Lab Invest; 1985 Dec; 53(6):705-9. PubMed ID: 2415776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal involvement of dialysis-related amyloidosis.
    Takahashi S; Morita T; Koda Y; Murayama H; Hirasawa Y
    Clin Nephrol; 1988 Sep; 30(3):168-71. PubMed ID: 3052956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amylosis: recent advances].
    M'Rad S; Ennafaa M; Ben Dridi M; Ben Ayed H
    Tunis Med; 1989 Dec; 67(12):749-51. PubMed ID: 2696190
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.
    Gejyo F; Homma N; Suzuki Y; Arakawa M
    N Engl J Med; 1986 Feb; 314(9):585-6. PubMed ID: 3080684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.